Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration
about
Anti-vascular endothelial growth factor for neovascular age-related macular degenerationSystemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationAnti-vascular endothelial growth factor for control of wound healing in glaucoma surgeryInterventions for age-related visual problems in patients with strokeStatins for age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaStatins for age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaMacular translocation for neovascular age-related macular degenerationSubmacular surgery for choroidal neovascularisation secondary to age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationAntiangiogenic therapy with interferon alfa for neovascular age-related macular degenerationUse of antivascular endothelial growth factor for diabetic macular edema.The treatment methods for post-stroke visual impairment: A systematic reviewThe concordance of care for age related macular degeneration with the chronic care model: a multi-centered cross-sectional study.Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews?DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the ω-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways.Evidence-based clinical guidelines for immigrants and refugees.Adult donor rod photoreceptors integrate into the mature mouse retina.Inhibition of proliferation, migration and invasiveness of endothelial murine cells culture induced by resveratrol.Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment.Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-LifeEffect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular DegenerationIntravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic ReviewThe effect of ranibizumab versus photodynamic therapy on DNA damage in patients with exudative macular degeneration.The treatment of wet age-related macular degeneration.Mechanism of inflammation in age-related macular degenerationThe role and therapeutic potential of melatonin in age-related ocular diseases.Age-Related Macular Degeneration: Clinical Findings following Treatment with Antiangiogenic Drugs.Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context.Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials.
P2860
Q24194251-11D7263C-6BFE-4170-B4A5-E4C06B3E2197Q24195003-53C21034-19FD-42FB-89C6-BC2A83375F9AQ24200772-BB74B5BD-242B-43D2-ABA8-7D048A482D8BQ24201153-1425B90D-E148-4138-85DA-C36322914457Q24201178-0C8D6E97-BB5E-48C7-811D-E788D35D3B88Q24201624-3FFBC81E-BF83-48FC-BC32-939F40FAC806Q24202071-00FFD476-1581-4878-A54B-2BFF014D77A3Q24240102-BA0CFF2C-BC7B-42DD-9989-52CDBB2F8C06Q24240165-D9D4CB49-5349-4169-B05C-E0FC28D042BCQ24241142-095F0AF7-D5FC-4898-95FF-36EC38B75B98Q24241790-6703D7AA-B006-4F9B-8B7A-E626DAF03279Q24243503-1822602F-548B-4242-99A0-0603BDA6F5BAQ24244534-DC2979B1-C5F0-45E1-819C-88E68CE39D1BQ33599732-AD2C3CEC-6D98-4F54-A068-6A0EB88D23D8Q33695324-1C5C1867-4801-4A64-BD0C-7A9716B2F7BAQ34301308-B62ED33B-2854-483B-B1E4-B75749919C45Q34510579-7301EDF4-EFBB-452A-B69D-71D55DD7CC8EQ34555655-830B36FE-1FA1-4DDB-9154-018C3983B732Q35201293-E6AEF7DF-B38E-453A-8FF4-040DAA933490Q35221330-62938432-F182-4A5E-8F6B-16CBAF0F893FQ35631662-D8D6E1EC-1800-4673-B943-ACB0ECE95A25Q35684611-AF793521-5F0A-4B3E-8C60-B87D93831DF1Q35737573-CFAF7F53-1798-47E3-8952-F73EE7BC2318Q36088747-336ED903-5EA4-4FBC-8010-F19B1291F27DQ36414769-C938E1A8-6D45-4622-85C5-4B66A3748043Q37230090-78E2139A-E747-4998-86DA-48B191B8DB63Q37527988-6F591792-1A4F-4EF3-A1C3-315233B07D48Q38064846-A7F3AA13-6076-46FE-B45A-5D52784947FCQ39402838-652CEBA9-9AC2-4ABB-976B-A10F566ACD02Q41810381-F10FAE7B-C2AB-4B01-A866-4D43FD2FF357Q47761710-E161F52C-42C1-4A0C-A47F-8673A8DA2B72Q51410130-1375E178-AE5D-4367-BD30-6FF6FD64A615Q55128789-F2FF8130-3E03-4223-81A0-9CA3002764CF
P2860
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antiangiogenic therapy with an ...... e-related macular degeneration
@ast
Antiangiogenic therapy with an ...... e-related macular degeneration
@en
Antiangiogenic therapy with an ...... e-related macular degeneration
@en-gb
Antiangiogenic therapy with an ...... e-related macular degeneration
@nl
type
label
Antiangiogenic therapy with an ...... e-related macular degeneration
@ast
Antiangiogenic therapy with an ...... e-related macular degeneration
@en
Antiangiogenic therapy with an ...... e-related macular degeneration
@en-gb
Antiangiogenic therapy with an ...... e-related macular degeneration
@nl
prefLabel
Antiangiogenic therapy with an ...... e-related macular degeneration
@ast
Antiangiogenic therapy with an ...... e-related macular degeneration
@en
Antiangiogenic therapy with an ...... e-related macular degeneration
@en-gb
Antiangiogenic therapy with an ...... e-related macular degeneration
@nl
P2860
P1476
Antiangiogenic therapy with an ...... e-related macular degeneration
@en
P2093
M G Krzystolik
S S Vedula
P2860
P304
P356
10.1002/14651858.CD005139.PUB2
P407
P577
2008-01-01T00:00:00Z